# RQ Biotechnology Ltd.: Biotechnology, London, United Kingdom

> RQ Biotechnology Ltd.: RQ Biotechnology Ltd. Based in London, United Kingdom. Founded 2022. What Millionrounds holds on them, and what we have not seen.

Source: https://millionrounds.com/startup/rq-biotechnology-ltd (Millionrounds; every figure on the page links to its filing or article)

United Kingdom · [Biotechnology startup](https://millionrounds.com/companies)

# RQ Biotechnology Ltd.

RQ Biotechnology Ltd.

Funding reported Last round: Series A

Biotechnology London, United Kingdom

Company summary

- **Founded:** 2022 4 years old
- **Team:** 19 11 to 50 people
- **Funding reported:** 112.5M as listed, currency not stated
- **Last round:** Series A Jun 2026

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for RQ Biotechnology Ltd. has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About RQ Biotechnology Ltd.

RQ Biotechnology Ltd.

(RQ Bio) is a UK-based biotechnology company founded in 2021 and headquartered in London. The company focuses on the discovery and development of long-acting monoclonal antibodies (LAAbs) aimed at providing protection against severe viral diseases. RQ Bio combines expertise in virus evolution, artificial intelligence, and high-throughput screening to create a pipeline of antiviral therapies. The company's lead product, RQB01, is designed to offer immediate and long-lasting protection against seasonal influenza, particularly for immunocompromised and high-risk individuals. RQ Bio is also engaged in developing therapies for a range of infectious diseases, including polio, rabies, measles, and COVID-19. The company collaborates with academic institutions like the University of Oxford and pharmaceutical partners such as AstraZeneca to advance its research and bring effective therapies to market. RQ Bio's mission is to ensure that vulnerable populations receive the protection they need, even when vaccines are insufficient.

## What company datasets say RQ Biotechnology Ltd. raised

Funding, as reported

Reported in all **112.5M** in the source's currency

Last round **Series A**

Last round size **114M**

Last round date **Jun 2026**

## Funding filed with regulators

RQ Biotechnology Ltd. filed one raise, $1.7M in all. Filings say how much was sold and to how many investors; they never name the investors.

- Dec 2022 **$1.7M** UK share allotment

## On 2 portfolio pages

Investors who name them

- [LifeArc Ventures](https://millionrounds.com/fund/lifearc-ventures)
- [Frazier Life Sciences](https://millionrounds.com/fund/frazier-life-sciences)

Each firm lists RQ Biotechnology Ltd. on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care viral mutation resistance antibody pipeline monoclonal antibodies rsv viral diseases long-acting monoclonal antibodies vaccine limitations immunocompromised protection influenza antibodies vulnerable populations infectious disease defense resilient antibody epitopes antibody development against variable viruses immunology viral infection therapies

Built with from their website

Squarespace ECommerce Viewport Meta Digital Ocean Spaces webpack OpenAI Priority Hints React Microsoft Exchange Microsoft 365 Apps & Services Mobile Friendly

+8 more

Vercel Open Graph Linkedin Marketing Solutions Next.js GoDaddy Domains Microsoft Exchange Online DigitalOcean Microsoft 365

- **Sector:** Biotechnology
- **Industry code:** NAICS 541714, SIC 8731
- **Region:** England
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/rq-bio)

## Biotechnology in United Kingdom

Startups like it

- [**CellCentric** Saffron Walden · founded 2004 *Raised*](https://millionrounds.com/company/cellcentric)
- [**Oxford BioTherapeutics** Oxford · founded 2004 *Raised*](https://millionrounds.com/company/oxford-biotherapeutics)
- [**Chroma Therapeutics** Milton · founded 2020](https://millionrounds.com/startup/chroma-therapeutics)
- [**Oxagen** Abingdon · founded 1996](https://millionrounds.com/startup/oxagen)
- [**ONI** Oxford · founded 2016](https://millionrounds.com/startup/oni-2)
- [**Oxular** Oxford · founded 2014](https://millionrounds.com/startup/oxular)
- [**Maxion Therapeutics** Cambridge · founded 2020](https://millionrounds.com/startup/maxion-therapeutics)
- [**PhoreMost Ltd** Cambridge · founded 2014](https://millionrounds.com/startup/phoremost-ltd)

## Is this your company?

Add your raise, your deck and your story, and put RQ Biotechnology Ltd. in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)